Trials / Completed
CompletedNCT02993744
Maternal Inflammatory Parameters Within Routine Treatment With Betamethasone
Assessment of Maternal Inflammatory Parameters Within Routine Treatment With Betamethasone Under Threat of Preterm Delivery
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 140 (actual)
- Sponsor
- Medical University of Vienna · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
It is the aim of this study to detect the effect of Betamethasone on the maternal inflammatory parameters C-reactive protein (CRP) and leukocytes of a pregnant woman under threat of preterm delivery, for example because of a cervical infection.
Detailed description
BACKGROUND Cortisone influences the maternal number of leukocytes and CRP of a pregnant woman. Because of that, it is difficult to know if the medical treatment of an infection was successful and accordingly if the diagnosis was justified. METHODS In this study, the blood results of 75 pregnant women under threat of preterm delivery (week of gestation 23+0 to 34+6), treated with Betamethasone will be analysed. 65 pregnant women without complications serve as control group.
Conditions
Timeline
- Start date
- 2016-09-01
- Primary completion
- 2017-05-01
- Completion
- 2017-05-01
- First posted
- 2016-12-15
- Last updated
- 2017-05-30
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT02993744. Inclusion in this directory is not an endorsement.